Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| clarithromycin (antibiotic)s[CFS] |
?
In vitro activities of rifabutin, azithromycin, ciprofloxacin, clarithromycin, clofazimine, ethambutol, and amikacin in combinations of two, three, and four drugs against Mycobacterium avium. Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother ) Vol: 40 Issue 3 Pages: 743-9 Pub: 1996 Mar Epub: Authors Yajko DM , Sanders CA , Madej JJ , Cawthon VL , Hadley WK , Html Article Publication |
| clarithromycin (antibiotic)s[CFS] |
?
Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium. Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother ) Vol: 42 Issue 11 Pages: 3006-8 Pub: 1998 Nov Epub: Authors Horgen L , Jerome A , Rastogi N , Html Article Publication |
| clarithromycin (antibiotic)s[CFS] |
?
The in-vitro anti-rickettsial activity of macrolides. The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 38 Issue 4 Pages: 727-31 Pub: 1996 Oct Epub: Authors Keysary A , Itzhaki A , Rubinstein E , Oron C , Keren G , Publication |
| clarithromycin (antibiotic)s[CFS] |
?
Comparison of Drug Resistance of Helicobacter pylori Between Children and Adults in Jilin, China. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology (Turk J Gastroenterol ) Vol: 32 Issue 12 Pages: 1012-1018 Pub: 2021 Dec Epub: Authors Wang L , Zhang J , Hu M , Pang X , Publication |
| clarithromycin (antibiotic)s[CFS] |
?
Unravelling the collateral damage of antibiotics on gut bacteria. Nature (Nature ) Vol: 599 Issue 7883 Pages: 120-124 Pub: 2021 Nov Epub: 2021 Oct 13 Authors Maier L , Goemans CV , Wirbel J , Kuhn M , Eberl C , Pruteanu M , Müller P , Garcia-Santamarina S , Cacace E , Zhang B , Gekeler C , Banerjee T , Anderson EE , Milanese A , Löber U , Forslund SK , Patil KR , Zimmermann M , Stecher B , Zeller G , Bork P , Typas A , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.